Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

INCY

Incyte (INCY)

Incyte Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INCY
DateTimeSourceHeadlineSymbolCompany
12/19/20194:47PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INCYIncyte Corporation
12/19/20198:00AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INCYIncyte Corporation
12/19/20197:30AMBusiness WireIncyte Names New Member to Its Board of DirectorsNASDAQ:INCYIncyte Corporation
12/18/20195:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
12/16/20194:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
12/12/20194:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
12/05/20198:00AMBusiness WireIncyte to Present at Upcoming Investor ConferenceNASDAQ:INCYIncyte Corporation
12/03/20194:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
12/03/20194:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
12/03/20194:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
11/27/20195:55PMBusiness WireIncyte gibt Annahme von NDA mit vorrangiger Prüfung für Pemigatinib zur Behandlung von Patienten mit Cholangiokarzinom beka...NASDAQ:INCYIncyte Corporation
11/27/20191:45PMBusiness WireIncyte annonce l’acceptation de sa demande d’examen prioritaire NDA du pemigatinib pour le traitement des patients attein...NASDAQ:INCYIncyte Corporation
11/27/20197:30AMBusiness WireIncyte Announces Acceptance and Priority Review of NDA for Pemigatinib as a Treatment for Patients with CholangiocarcinomaNASDAQ:INCYIncyte Corporation
11/26/20194:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
11/26/20194:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
11/26/20194:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
11/25/20198:00AMBusiness WireData from Incyte’s Oncology Portfolio Accepted for Presentation at the 61st Annual ASH MeetingNASDAQ:INCYIncyte Corporation
11/19/20195:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
11/14/20195:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
11/14/20198:00AMBusiness WireIncyte to Present at Upcoming Investor ConferenceNASDAQ:INCYIncyte Corporation
11/08/20195:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
11/07/20194:06PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:INCYIncyte Corporation
11/07/20191:25PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:INCYIncyte Corporation
11/07/20191:17PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:INCYIncyte Corporation
11/07/20191:06PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:INCYIncyte Corporation
11/07/201912:59PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:INCYIncyte Corporation
11/05/20195:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
11/05/20194:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
10/31/20194:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
10/31/20194:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
 Showing the most relevant articles for your search:NASDAQ:INCY